Innovaderma Plc (LON:IDP)‘s stock had its “corporate” rating reiterated by research analysts at FinnCap in a report issued on Friday. They currently have a GBX 400 ($5.31) price objective on the stock. FinnCap’s target price points to a potential upside of 24.03% from the company’s previous close.

Shares of Innovaderma Plc (LON IDP) opened at 322.50 on Friday. The company has a 50-day moving average of GBX 348.04 and a 200-day moving average of GBX 302.14. The firm’s market cap is GBX 40.54 million. Innovaderma Plc has a 1-year low of GBX 71.00 and a 1-year high of GBX 410.50.

Innovaderma Plc (LON:IDP) last released its quarterly earnings results on Tuesday, September 12th. The company reported GBX 6 ($0.08) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of GBX 4.70 ($0.06) by GBX 1.30 ($0.02). The company had revenue of GBX 886 million for the quarter.

COPYRIGHT VIOLATION WARNING: This story was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at

In other Innovaderma Plc news, insider Ross Andrews acquired 15,000 shares of the business’s stock in a transaction on Thursday, July 27th. The stock was purchased at an average price of GBX 343 ($4.55) per share, for a total transaction of £51,450 ($68,245.13).

Receive News & Stock Ratings for Innovaderma Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovaderma Plc and related stocks with our FREE daily email newsletter.